Activity

Filter

Cancel
Date Panel Item Activity
7 actions
Intellectual disability syndromic and non-syndromic v0.3868 FARSA Zornitza Stark Marked gene: FARSA as ready
Intellectual disability syndromic and non-syndromic v0.3868 FARSA Zornitza Stark Gene: farsa has been classified as Green List (High Evidence).
Intellectual disability syndromic and non-syndromic v0.3863 FARSA Chirag Patel Classified gene: FARSA as Green List (high evidence)
Intellectual disability syndromic and non-syndromic v0.3863 FARSA Chirag Patel Gene: farsa has been classified as Green List (High Evidence).
Intellectual disability syndromic and non-syndromic v0.3863 FARSA Chirag Patel Classified gene: FARSA as Green List (high evidence)
Intellectual disability syndromic and non-syndromic v0.3863 FARSA Chirag Patel Gene: farsa has been classified as Green List (High Evidence).
Intellectual disability syndromic and non-syndromic v0.3862 FARSA Chirag Patel gene: FARSA was added
gene: FARSA was added to Intellectual disability syndromic and non-syndromic. Sources: Literature
Mode of inheritance for gene: FARSA was set to BIALLELIC, autosomal or pseudoautosomal
Publications for gene: FARSA were set to PMID: 33598926
Phenotypes for gene: FARSA were set to Rajab interstitial lung disease with brain calcifications 2
Review for gene: FARSA was set to GREEN
gene: FARSA was marked as current diagnostic
Added comment: FARSA is a subunit with FARSB to form FARS1 enzyme. Bi-allelic mutations in FARSB are well described.
Schuch et al. (2021) report 3 unrelated individuals with bi-allelic variants in FARSA. Identified through WES and variants segregated with disease. Functional evidence was obtained with reduced FARS1 enzyme activity levels in fibroblasts or EBV-transformed lymphoblastoid cell lines (EBV-LCLs) of patients. Common to all was a chronic interstitial lung disease starting early in life and characterized by bilateral ground-glass opacification on HR-CT, and cholesterol pneumonitis in lung histology. Additional abnormalities in other organ systems include liver disease, neurological manifestations, and growth restriction.
Sources: Literature